Showing 1 – 2 of 2
Relevance | Newest | Oldest |
  • Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults

    Abstract Full Text
    open access
    ÁñÁ«ÊÓƵ Netw Open. 2024; 7(4):e244954. 10.1001/jamanetworkopen.2024.4954

    This cohort study examines disease severity among adults hospitalized with respiratory syncytial virus (RSV) and compares it with the severity of COVID-19 and influenza by vaccination status.

  • Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus

    Abstract Full Text
    online first
    JAMA. 2024; 10.1001/jama.2024.5859

    This Viewpoint discusses recommendations from the US Centers for Disease Control and Prevention for newly licensed immunizations for respiratory syncytial virus in infants, children with high-risk conditions, and older adults.